Financials data is unavailable for this security.
Cash flow in USDView more
In 2024, Vistagen Therapeutics Inc increased its cash reserves by 616.23%, or 102.53m. Cash Flow from Financing totalled 128.40m or 12,067.86% of revenues. In addition the company used 25.81m for operations while cash used for investing totalled 61.00k.
Cash flow per share | -1.32 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 3.87 |
---|---|
Tangible book value per share | 3.87 |
More ▼
Balance sheet in USDView more
Current ratio | 17.77 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼